Vital KSK Holdings Inc (FRA:4GX) Stock Price, Trades & News

Vital KSK Holdings Inc engaged in the wholesale and retail of pharmaceutical products. It operates through the Pharmaceutical Wholesale and Other segments. The Pharmaceutical Wholesale segment sells medicines, diagnostics, and medical devices to hospitals, medical institutions, and health practitioners. The Other segment includes retail of pharmaceutical products, wholesale of agrochemical and veterinary drugs, transportation, nursing care services, and medical consultancies. All the business activity of the group is primarily functioned through Japan and distributes its product within the Korean and to overseas market.

Financial Strength

7/10

Name	Current	Vs Industry
Cash-To-Debt	4.08
Equity-to-Asset	0.36
Debt-to-Equity	0.05
Debt-to-EBITDA	0.37
Interest Coverage	56.01
Piotroski F-Score	6/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	2.66	Distress Grey Safe
Beneish M-Score	-2.35	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

3/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	4.2
	3-Year EBITDA Growth Rate	13.4
	3-Year EPS without NRI Growth Rate	15.1
	3-Year FCF Growth Rate	63.4
	3-Year Book Growth Rate	8.2

Momentum Rank

3/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	70.59
	9-Day RSI	63.44
	14-Day RSI	60.18
	3-1 Month Momentum %	7.36
	6-1 Month Momentum %	17.18

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.05
	Quick Ratio	0.88
	Cash Ratio	0.12
	Days Inventory	21.35
	Days Sales Outstanding	75.41
	Days Payable	114.6

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	2.19
	3-Year Dividend Growth Rate	21.5
	Forward Dividend Yield %	4.27
	5-Year Yield-on-Cost %	10.18
	3-Year Average Share Buyback Ratio	2.2
	Shareholder Yield %	4.97

Profitability Rank

5/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	8.14
	Operating Margin %	0.63
	Net Margin %	1.14
	EBITDA Margin %	2.47
	FCF Margin %	-0.07
	OCF Margin %	0.77
	ROE %	6.34
	ROA %	2.19
	ROIC %	1.89
	3-Year ROIIC %	1.03
	ROC (Joel Greenblatt) %	22.27
	ROCE %	8.66
	Years of Profitability over Past 10-Year	10
	Moat Score	3
	Tariff Resilience Score	5

GF Value Rank

6/10

	Name	Current	Vs Industry		Vs History
	PE Ratio	11.44
	PE Ratio without NRI	16.68
	Shiller PE Ratio	17.06
	PEG Ratio	0.76
	PS Ratio	0.13
	PB Ratio	0.7
	Price-to-Tangible-Book	0.75
	Price-to-Operating-Cash-Flow	16.63
	EV-to-EBIT	5.74
	EV-to-EBITDA	4.22
	EV-to-Revenue	0.1
	EV-to-FCF	-147.79
	Price-to-GF-Value	1.26
	Price-to-Projected-FCF	1.26
	Price-to-Median-PS-Value	1.27
	Price-to-Peter-Lynch-Fair-Value	0.65
	Price-to-Graham-Number	0.75
	Earnings Yield (Greenblatt) %	17.43
	FCF Yield %	-0.54
	Forward Rate of Return (Yacktman) %	18.85

Financials

Annual Quarterly TTM

FRA:4GX's 30-Y Financials

AAPL

Income Statement Breakdown FY

Annual Quarterly

Not Enough Data

AAPL

Balance Sheet Breakdown

Annual Quarterly

Not Enough Data

AAPL

Cashflow Statement Breakdown

Annual Quarterly

Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Value % YoY

Historical Operating Revenue by Geographic Region

Value % YoY

See Details

5-Step DuPont Analysis as of

Annual Quarterly

Not Enough Data

Guru Trades

See Details

Insider Trades

See Details

Peter Lynch Chart

Y-axis scale:

Log Linear

Interactive Chart

Performance

Dividend

Log

Bar

Annualized Return %

Symbol	1 Week	1 Month	3 Months	6 Months	YTD	1 Year	3 Years	5 Years	10 Years

Total Annual Return %

Symbol	2026	2025	2024	2023	2022	2021	2020	2019	2018	2017

Vital KSK Holdings Inc Executives

Details

GF Value™: €7.01

FRA:4GX

Valuation Chart

Year:

Warning Signs

Warning! GuruFocus detected 6 Medium warning signs with 4GX. Try a 7-Day Free Trial to check it out.

Analyst Estimate

Annual Quarterly

Key Statistics

	Name	Value
	Revenue (TTM) (Mil €)	3,406.434
	EPS (TTM) (€)	0.82
	Beta	-
	3-Year Sharpe Ratio	-
	3-Year Sortino Ratio	-
	Volatility %	-
	14-Day RSI	60.18
	14-Day ATR (€)	0.08516
	20-Day SMA (€)	8.6825
	12-1 Month Momentum %	-
	52-Week Range (€)	7.181 - 9.05
	Shares Outstanding (Mil)	47.83

Piotroski F-Score Details

Year:

	Component	Result
	Piotroski F-Score	6
	Positive ROA
	Positive CFROA
	Higher ROA yoy
	CFROA > ROA
	Lower Leverage yoy
	Higher Current Ratio yoy
	Less Shares Outstanding yoy
	Higher Gross Margin yoy
	Higher Asset Turnover yoy

Vital KSK Holdings Inc Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Vital KSK Holdings Inc Stock Events

Financials Calendars

	Event	Date	Price (€)
	JPY 35.000000 Cash Dividend	2026-09-29	In 33 days
	JPY 36.000000 Cash Dividend	2026-03-30	7.93 (+0.00%)

Show

Entries

Vital KSK Holdings Inc Frequently Asked Questions

What is Vital KSK Holdings Inc(FRA:4GX)'s stock price today?

The current price of FRA:4GX is €8.85. The 52 week high of FRA:4GX is €9.05 and 52 week low is €7.18.

When is next earnings date of Vital KSK Holdings Inc(FRA:4GX)?

The next earnings date of Vital KSK Holdings Inc(FRA:4GX) is .

Does Vital KSK Holdings Inc(FRA:4GX) pay dividends? If so, how much?

The Dividend Yield % of Vital KSK Holdings Inc(FRA:4GX) is 2.19% (As of Today), Highest Dividend Payout Ratio of Vital KSK Holdings Inc(FRA:4GX) was 0.68. The lowest was 0.3. And the median was 0.43. The Forward Dividend Yield % of Vital KSK Holdings Inc(FRA:4GX) is 4.27%. For more information regarding to dividend, please check our Dividend Page.

Press Release

	Subject	Date
No Press Release

Articles on Vital KSK Holdings Inc

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.